Southwest Research Institute scientists and engineers have developed a custom large language model (LLM) to accelerate drug design and discovery. Subscribe to our newsletter for the latest sci-tech ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...

Thomas Grant secures $2.18 million grant to pioneer protein-studying tool that could lead to new and personalized medicine.

DUBLIN--(BUSINESS WIRE)--The "AI Driven Drug Discovery Patent Landscape Report 2024" report has been added to ResearchAndMarkets.com's offering. The AI-driven drug discovery report provides a detailed ...

AUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Absci (ABSI), a clinical-stage biotech company advancing novel therapeutics with generative AI, today announced a ...

Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...

This article is based on a poster originally authored by Peter Hsueh, Lili Qin, Jane Liu and Wenlin Ren. Target proteins are central to the antibody discovery process. These reagents play a critical ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

Matthew SegallCEOOptibrium  Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO ...

Computational drug discovery and design embodies the integration of advanced computational methods, machine learning, and cheminformatics to streamline the identification and optimisation of ...